Spyre Therapeutics Inc.
03/04/2026 | Press release | Distributed by Public on 03/05/2026 05:04
Notice of Effectiveness (Form EFFECT)
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | March 4, 2026 |
| Accession Number: | 0001628280-26-012785 | ||||||
| Submission Type: | POS AM | ||||||
|
|||||||
Spyre Therapeutics Inc. published this content on March 04, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on March 05, 2026 at 11:05 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]